Provided by Tiger Trade Technology Pte. Ltd.

Syndax Pharmaceuticals

19.66
+0.01000.05%
Volume:769.30K
Turnover:15.06M
Market Cap:1.76B
PE:-7.83
High:19.87
Open:19.69
Low:19.17
Close:19.65
52wk High:25.59
52wk Low:12.99
Shares:89.30M
Float Shares:80.30M
Volume Ratio:0.76
T/O Rate:0.96%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.5100
EPS(LYR):-3.2949
ROE:-255.93%
ROA:-18.67%
PB:116.27
PE(LYR):-5.97

Loading ...

Is Strong SAVE Trial Data Altering The Investment Case For Syndax Pharmaceuticals (SNDX)?

Simply Wall St.
·
Jun 21

Semiconductor Stocks Lead Market Surge, US Equity Funds See Record Inflows, Nikkei Hits 70,000

Deep News
·
Jun 20

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Jun 15

Syndax Pharmaceuticals (SNDX) Stock Valuation After Positive SAVE Trial Data In High-Risk Leukemia

Simply Wall St.
·
Jun 15

Syndax Head of R&D, CMO Nicholas A.J. Botwood disposes of USD 1,183,151 in common shares

Reuters
·
Jun 13

Syndax Pharmaceuticals Price Target Maintained With a $40.00/Share by HC Wainwright & Co.

Dow Jones
·
Jun 12

Syndax price target lowered to $31 from $34 at Guggenheim

TIPRANKS
·
Jun 12

Syndax presents data from SAVE trial at EHA

TIPRANKS
·
Jun 11

Syndax Pharmaceuticals Reports Positive Data From Leukemia Combo Drug Trial

MT Newswires Live
·
Jun 11

Syndax says revumenib plus intensive chemo posts 97% remission rate in Phase 1 newly diagnosed AML trial at EHA 2026

Reuters
·
Jun 11

Syndax reports 88% response rate in SAVE trial of Revuforj combo for relapsed/refractory AML

Reuters
·
Jun 11

Syndax Pharmaceuticals Reports New Significant Financial Obligation Agreement

TIPRANKS
·
Jun 11

Syndax Pharmaceuticals - Issues $250 Mln of 2.25% Convertible Senior Notes Due 2031 - SEC Filing

THOMSON REUTERS
·
Jun 11

Syndax Pharmaceuticals issues USD 250 million 2.25% convertible senior notes due 2031 in private placement

Reuters
·
Jun 11

Syndax Pharmaceuticals shareholders approve 2026 equity incentive plan at annual meeting

Reuters
·
Jun 11

US Stocks Experience Sharp Turn: Nasdaq Dives 2% in Late Trading, Micron Technology Plunges Over 4.8%

Stock News
·
Jun 09

Morgan Stanley Weighs In on NVIDIA 'Memory Halving' Rumor: A Real Shortage, Supply Constraints Emerge as AI's Biggest Hurdle

Deep News
·
Jun 08

Top 20 US Stocks by Trading Volume on June 6: Broadcom's Outlook Disappoints, Shares Extend Losses to Third Day

Deep News
·
Jun 06

Syndax grants stock options for 66,700 shares to four new employees under inducement plan

Reuters
·
Jun 05

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire
·
Jun 05